Lacosamide Solution
Product Images NDC 59651-016

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 59651-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Lacosamide Fig1)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' comparing seizure reduction percentages among placebo and Lacosamide doses (200, 400, 600 mg/day) across three studies. The y-axis shows median percentage change from baseline, ranging from 0% to 45%. Bars indicate higher reductions for Lacosamide doses than placebo, with statistically significant differences marked.*

FDA Label Image

Figure 2 (Lacosamide Fig2)

A line graph displaying the proportion of patients by responder rate for Lacosamide and placebo groups across multiple studies. The vertical axis represents responder rate from -100% (worsening) to 100% (improvement), and the horizontal axis shows percent of patients from 100% to 0%. Four lines depict placebo and Lacosamide doses of 200 mg/day, 400 mg/day, and 600 mg/day, illustrating varying responder rates among patient groups.*

FDA Label Image

Figure 3 (Lacosamide Fig3)

A Kaplan-Meier survival curve showing time to second PGTC seizure comparing Lacosamide (n=118) and placebo (n=121) groups over approximately 170 days. The y-axis is proportion of patients, and the x-axis is time in days. The graph includes patient numbers at risk over time and statistical values including p-value, hazard ratio, and confidence interval.*

FDA Label Image

Package Label-principal Display Panel (10 mg/mL Container (200mL))

Label for Lacosamide Oral Solution, USP 10 mg/mL by Aurobindo Pharma Limited. The label shows 200 mL bottle size, NDC 59651-016-02, with instructions for storage and usage. It includes warnings for phenylketonurics, pharmacist attention note, and distributor information by Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Lacosamide Str)

Chemical structure of lacosamide, showing its molecular arrangement with a benzyl group, amide functionality, and other characteristic chemical features corresponding to the active ingredient lacosamide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.